HDFC Life Insurance Company
- Market Cap
- ₹1,27,889 Cr
- P/E
- 62.23
Key Fundamentals
LargecapInsuranceFinancial ServicesPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 10.30%
- Debt to Equity
- 0.16
- EPS (TTM)
- ₹9.46
- Book Value
- ₹89.61
- Market Cap
- ₹1,27,889 Cr
- P/E (TTM)
- 62.23
- P/B
- 6.57
- ROE
- 11.30%
- Dividend Yield
- 0.36%
- EBITDA
- ₹2,438 Cr
- 52W High
- ₹788.50
- 52W Low
- ₹508.05
- Day Range
- ₹567.65 – ₹589.90
- Volume
- 45,10,623
Peer Comparison
Financial Services › Insurance › Life Insurance
| 410.70 | 8.37 | 5,19,535 | 2.74 | 2.50% | 37.80% | 35.10% | 10,17,885 | 62,071 | |
| 1,826.50 | 69.00 | 1,83,272 | 8.92 | 0.15% | 13.70% | 15.00% | 1,21,160 | 2,656 | |
| 588.65 | 62.23 | 1,27,889 | 6.57 | 0.36% | 11.30% | 10.30% | 1,07,513 | 2,048 | |
| 462.00 | 41.66 | 67,047 | 4.91 | 0.37% | 12.60% | 10.10% | 52,714 | 1,608 | |
| 1,435.10 | 266.25 | 49,527 | 8.66 | 0.00% | 1.52% | 2.87% | 51,631 | 231 | |
| 127.32 | 90.30 | 12,095 | 7.38 | 0.31% | 8.11% | 8.35% | 12,482 | 134 | |
| Median 6 companies | 525.33 | 65.62 | 97,468 | 6.98 | 0.33% | 11.95% | 10.20% | 80,114 | 1,828 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 97/100
Category scores
- Quality
- 53
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 35
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 59
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 2
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 33
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 43
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 25.3%
Weaknesses
5- Stock is trading at 6.57 times its book value
- The company has delivered a poor sales growth of 6.81% over past five years.
- Tax rate seems low
- Company has a low return on equity of 11.1% over last 3 years.
- Earnings include an other income of Rs.1,021 Cr.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 2 | 6 | 11 |
| Oscillators | Bullish | 0 | 6 | 3 |
| Moving Averages | Strong Bullish | 2 | 0 | 8 |
Oscillators
Bullish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 61.94
- Neutral
- MACD (12,26,9)
- 13.93
- Bullish
- SMA (50)
- 546.18
- Bullish
- SMA (200)
- 588.72
- Bearish
As of
Analyst Rating
33 of 33 analysts rate Buy, 0 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +18.55% |
|---|---|
| 5Y | +6.81% |
| 3Y | +12.30% |
| 1Y | +2.59% |
| TTM | +17.37% |
Net profit
| 10Y | +8.87% |
|---|---|
| 5Y | +7.04% |
| 3Y | +11.81% |
| 1Y | +5.58% |
| TTM | +8.25% |
Operating cash flow
| 10Y | +14.81% |
|---|---|
| 5Y | +18.45% |
| 3Y | +48.69% |
| 1Y | +45.06% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −3.49 pp |
|---|---|
| 5Y | +0.03 pp |
| 3Y | +1.65 pp |
| 1Y | +0.70 pp |
| TTM | −0.59 pp |
Revenue by year
| Mar 2017 | ₹30,647 Cr |
|---|---|
| Mar 2018 | ₹32,260 Cr |
| Mar 2019 | ₹38,855 Cr |
| Mar 2020 | ₹29,380 Cr |
| Mar 2021 | ₹71,528 Cr |
| Mar 2022 | ₹67,126 Cr |
| Mar 2023 | ₹70,207 Cr |
| Mar 2024 | ₹1,01,482 Cr |
| Mar 2025 | ₹96,922 Cr |
| Mar 2026 | ₹99,432 Cr |
Net profit by year
| Mar 2017 | ₹887 Cr |
|---|---|
| Mar 2018 | ₹1,107 Cr |
| Mar 2019 | ₹1,278 Cr |
| Mar 2020 | ₹1,297 Cr |
| Mar 2021 | ₹1,361 Cr |
| Mar 2022 | ₹1,327 Cr |
| Mar 2023 | ₹1,368 Cr |
| Mar 2024 | ₹1,574 Cr |
| Mar 2025 | ₹1,811 Cr |
| Mar 2026 | ₹1,912 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
HDFC Life Insurance trades at ₹577.05 as of 2026-11-19 with a market cap of ₹1,25,369 Cr. The stock commands a PE of 61x and a PB of 6.44x, reflecting premium valuations, while compounded sales growth over 10 years stands at 19% and ROE over the last year is 11%. The stock is down 24% over the past one year and trades 26.8% below its 52-week high of ₹788.50.
- Strong long-term revenue compounding with 10-year compounded sales growth of 19%, indicating consistent business expansion in India's underpenetrated life insurance market
- TTM sales growth has accelerated to 17%, well above the 3-year and 5-year compounded sales growth rates of 12% and 7% respectively, signalling a recent recovery in top-line momentum
- Conservative balance sheet with a debt-to-equity ratio of just 0.17, keeping financial risk low for a financial services company
- Consistent dividend payout of 25.3%, providing a degree of capital return to shareholders even as the company reinvests for growth
- 10-year compounded profit growth of 9% alongside 10-year compounded sales growth of 19% demonstrates sustained profitability through multiple market cycles
- 3-year compounded profit growth of 12% exceeds the 5-year rate of 7%, suggesting an improving earnings trajectory in recent years
- The stock trades at ₹577.05, which is 13.6% above its 52-week low of ₹508.05, indicating some support has formed after the recent correction
- The stock trades at 6.44x book value, well above typical financial services peers, raising concerns about overpayment relative to net assets
- Stock price CAGR of -24% over 1 year and -4% over both 3 and 5 years shows persistent destruction of shareholder value despite business growth
- Return on equity stands at 10.77% (and 11% on a 3-year average), which is modest for a company commanding over 6x price-to-book, implying the market is pricing in ROE expansion that has not yet materialised
- 5-year compounded sales growth of only 7% contrasts sharply with the 10-year figure of 19%, pointing to a meaningful slowdown in the medium-term growth trajectory
- Earnings include other income of ₹1,021 Cr, which raises questions about the quality and sustainability of reported profits
- Dividend yield of just 0.36% offers negligible income support, meaning investor returns depend almost entirely on capital appreciation from an already expensive valuation
- ROCE of 0.59% is extremely low, suggesting the company generates very little return on total capital employed relative to the premium valuation investors are paying
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: HDFC Life delivered solid H1FY27 results with double-digit growth in both VNB (12%) and PAT (13%), alongside market share gains in individual APE. No material headwinds are visible in recent news flow. The company is actively pursuing growth levers including a GIFT City expansion and capital raising via NCDs. The trend is constructive, with execution on profitability metrics and strategic expansion both tracking well.
- H1FY27 VNB up 12% Oct 23
HDFC Life reported H1FY27 Value of New Business at ₹2,037 crore, up 12% YoY. PAT grew 13% to ₹1,119 crore with individual APE up 9% and market share gains.
- ₹500 crore NCD issuance planned Nov 11
Committee meeting scheduled for November 16, 2026 to finalize terms for issuing subordinated NCDs up to ₹500 crore via private placement.
- Investor meets Nov 16-30 Nov 10
HDFC Life will interact with investors at six conferences across Mumbai and Dubai from November 16 to 30, 2026.
- GIFT City office approval sought Oct 27
Postal ballot initiated to seek member approval for establishing an IFSC Insurance Office at GIFT City. Remote e-voting opened October 28, 2026.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23,142 | 26,927 | 28,041 | 26,934 | 28,497 | 17,300 | 24,191 | 29,463 | 20,651 | 29,428 | 19,890 | 33,759 | 24,437 |
| Expenses | 23,557 | 26,663 | 27,766 | 26,623 | 28,807 | 16,852 | 23,814 | 29,024 | 20,336 | 29,157 | 19,782 | 33,253 | 24,105 |
| Operating Profit | −415 | 264 | 275 | 311 | −310 | 448 | 377 | 439 | 315 | 271 | 108 | 506 | 332 |
| OPM % | −1.8% | 1% | 1% | 1.2% | −1.1% | 2.6% | 1.6% | 1.5% | 1.5% | 0.9% | 0.6% | 1.5% | 1.4% |
| Other Income | 136 | 103 | 174 | 90 | 279 | −29 | 124 | 164 | 157 | 174 | 428 | 171 | 247 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | −279 | 367 | 450 | 401 | −30 | 419 | 500 | 604 | 471 | 445 | 537 | 677 | 579 |
| Tax % | −235% | 0% | 8% | −20% | −1541% | −1% | 5% | 9% | 5% | 6% | 7% | 10% | 10% |
| Net Profit | 378 | 368 | 412 | 479 | 435 | 421 | 475 | 548 | 448 | 418 | 497 | 611 | 522 |
| EPS (₹) | 1.76 | 1.71 | 1.91 | 2.23 | 2.02 | 1.96 | 2.21 | 2.54 | 2.08 | 1.94 | 2.31 | 2.81 | 2.40 |
| YoY Sales growth | 0 | 38 | 34 | 15 | 23 | −36 | −14 | 9 | −28 | 70 | −18 | 15 | 18 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27,215 | 18,141 | 30,647 | 32,260 | 38,855 | 29,380 | 71,528 | 67,126 | 70,207 | 1,01,482 | 96,922 | 99,432 | 1,07,513 |
| Expenses | 26,341 | 17,187 | 29,674 | 31,186 | 37,640 | 28,239 | 70,294 | 66,348 | 70,127 | 1,00,836 | 95,894 | 97,679 | 1,06,296 |
| Operating Profit | 874 | 953 | 972 | 1,074 | 1,215 | 1,141 | 1,235 | 778 | 80 | 646 | 1,028 | 1,753 | 1,217 |
| OPM % | 3.2% | 5% | 3.2% | 3.3% | 3.1% | 3.9% | 1.7% | 1.2% | 0.1% | 0.6% | 1.1% | 1.8% | 1.1% |
| Other Income | 79 | 108 | 139 | 282 | 136 | 369 | 445 | 766 | 1,437 | 410 | 366 | 465 | 1,021 |
| Interest | −14 | 8 | 9 | 11 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 43 | 45 | 41 | 44 | 45 | 47 | 51 | 56 | 76 | 79 | 104 | 161 | 0 |
| PBT | 924 | 1,008 | 1,061 | 1,300 | 1,291 | 1,463 | 1,629 | 1,487 | 1,441 | 977 | 1,290 | 2,057 | 2,238 |
| Tax % | 15% | 19% | 16% | 15% | 1% | 11% | 16% | 11% | 5% | −61% | −40% | 7% | — |
| Net Profit | 786 | 817 | 887 | 1,107 | 1,278 | 1,297 | 1,361 | 1,327 | 1,368 | 1,574 | 1,811 | 1,912 | 2,048 |
| EPS (₹) | 3.91 | 4.07 | 4.41 | 5.50 | 6.33 | 6.43 | 6.73 | 6.28 | 6.37 | 7.32 | 8.41 | 8.86 | 9.46 |
| Div. Payout % | 18% | 22% | 25% | 25% | 26% | 0% | 30% | 27% | 30% | 27% | 25% | 24% | — |
| Sales growth | 59 | −33 | 69 | 5 | 20 | −24 | 143 | −6 | 5 | 45 | −4 | 3 | 17 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1,995 | 1,995 | 1,998 | 2,012 | 2,017 | 2,019 | 2,021 | 2,113 | 2,149 | 2,151 | 2,153 | 2,158 | 2,173 |
| Reserves | 546 | 1,108 | 1,828 | 2,693 | 3,625 | 4,788 | 6,619 | 13,501 | 10,844 | 12,515 | 14,002 | 15,592 | 17,295 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 600 | 600 | 950 | 950 | 2,950 | 3,099 | 3,099 |
| Other Liabilities | 66,767 | 73,441 | 91,270 | 1,05,778 | 1,24,378 | 1,25,417 | 1,70,415 | 2,14,521 | 2,34,126 | 2,87,071 | 3,30,307 | 3,69,654 | 4,01,179 |
| Total Liabilities | 69,309 | 76,544 | 95,097 | 1,10,483 | 1,30,020 | 1,32,224 | 1,79,655 | 2,30,734 | 2,48,069 | 3,02,687 | 3,49,412 | 3,90,502 | 4,23,745 |
| Fixed Assets | 346 | 335 | 337 | 336 | 370 | 322 | 585 | 6,605 | 997 | 1,549 | 2,143 | 2,716 | 788 |
| CWIP | 6 | 12 | 16 | 5 | 10 | 8 | 14 | 20 | 31 | 28 | 109 | 139 | 0 |
| Investments | 67,024 | 74,144 | 91,723 | 1,06,590 | 1,24,958 | 1,27,256 | 1,73,564 | 2,16,551 | 2,38,197 | 2,91,128 | 3,34,756 | 3,73,340 | 4,10,087 |
| Other Assets | 1,932 | 2,053 | 3,020 | 3,551 | 4,682 | 4,637 | 5,493 | 7,559 | 8,844 | 9,982 | 12,404 | 14,308 | 12,871 |
| Total Assets | 69,309 | 76,544 | 95,097 | 1,10,483 | 1,30,020 | 1,32,224 | 1,79,655 | 2,30,734 | 2,48,069 | 3,02,687 | 3,49,412 | 3,90,502 | 4,23,745 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 4,459 | 5,687 | 6,230 | 6,739 | 9,868 | 7,388 | 9,703 | 5,943 | 6,883 | 10,721 | 15,597 | 22,625 |
| Investing | −3,514 | −3,962 | −5,177 | −4,421 | −10,182 | −7,789 | −8,952 | −801 | −10,071 | −13,622 | −13,633 | −23,849 |
| Financing | −168 | −212 | −236 | −196 | −337 | 38 | 678 | −238 | 1,985 | −403 | 1,607 | −275 |
| Net Cash Flow | 777 | 1,513 | 817 | 2,122 | −651 | −364 | 1,429 | 4,904 | −1,203 | −3,304 | 3,572 | −1,499 |
| Free Cash Flow | 4,352 | 5,654 | 6,183 | 6,706 | 9,825 | 7,351 | 9,643 | 5,887 | 6,797 | 10,587 | 15,300 | 22,341 |
| CFO/EBITDA | 510 | 597 | 641 | 627 | 813 | 672 | 806 | 789 | 9,190 | 1,444 | 1,543 | 1,302 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | −11 | −27 | −20 | −25 | −16 | −17 | −13 | −11 | −12 | −8 | −6 | −6 |
| ROCE % | 41% | 36% | 31% | 31% | 23% | 24% | 20% | 12% | 10% | 5% | 7% | 10% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view HDFC Life Insurance insights
38 extracted metrics across FY07–FY27.
Documents
- Concall · Oct 2026Transcript PPT Recording
- Q1 FY27 concall · Jul 2026Transcript PPT Recording
- Concall · Apr 2026Transcript PPT Recording
- Q3 FY26 concall · Jan 2026Transcript PPT Recording
- Concall · Oct 2025Transcript PPT
- 16 Nov 2026
- 21 Sep 2026
- 31 Aug 2026
- 27 Jan 2026
- 28 Nov 2025
- General announcements 16 Nov 2026
- General announcements 11 Nov 2026
Frequently Asked Questions about HDFC Life Insurance Company
What does HDFC Life Insurance Company Ltd do?
Where is HDFC Life Insurance Company Ltd (HDFCLIFE) listed?
Which sector does HDFC Life Insurance Company Ltd belong to?
What is the market capitalisation of HDFC Life Insurance Company Ltd?
What is the PE ratio of HDFC Life Insurance Company Ltd?
What is the 52-week high and low of HDFC Life Insurance Company Ltd?
Does HDFC Life Insurance Company Ltd pay dividends?
What is the Return on Equity (ROE) of HDFC Life Insurance Company Ltd?
Company Information
HDFC Life Insurance Company is engaged in carrying on the business of life insurance. The Company offers a range of individual and group insurance solutions. The portfolio comprises of various insurance and investment products such as Protection, Pension, Savings,
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/HDFCLIFE.md for HDFC Life Insurance Company Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.